| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.5 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |